$25.6
Currently 14 wall-street analysts regularly analyze the financials of Celldex Therapeutics, Inc. on a frequent basis to provide recommendations along with target share price. 14 analysts offering 12-month price forecasts for Celldex Therapeutics, Inc. (CLDX) have a share price target of $53.36. This median of share price forecast represents a 108.43% upside from the latest price of $25.6 as on 21.12.25.
As per the chart shown above, analysts believe that the Celldex Therapeutics, Inc. (CLDX) share price will touch around $53.36 in next 12-months.
Below is a chart showing the percentage difference between Celldex Therapeutics, Inc.'s share price and its median forecast price. As on 21.12.25, the difference is -51.42%
Based on 14 analysts tracking and researching Celldex Therapeutics, Inc. (CLDX) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 7 | 7 | 7 |
| Outperform | 5 | 5 | 5 |
| Hold | 2 | 2 | 2 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |